3rd Symposium on Current Strategies in the Treatment of Multiple Myeloma, Lymphoma and Leukemia

Jointly provided by A. Webb Roberts Center for CME of Baylor Health Care System and CancerNet.

This activity is supported in part by independent education grants from Onyx Pharmaceuticals, Millennium Pharmaceuticals, Seattle Genetics , Genentech, Amgen.

Release date: July 28, 2014

Valid through: July 28, 2015

Target Audience:

This webcast is directed primarily to hematologists/oncologists, radiation oncologists, researchers, pharmacists, registered nurses, physician assistants, nurse practitioners and fellows in training interested in new developments for treatment of hematological malignancies. No specific skill or knowledge other than a basic training in hematology/oncology is required for successful participation in this activity.

Statement of Need / Program Overview:

This webcast is intended to improve care of patients with hematological malignancies by accelerating adoption of new guidelines and evidence-based practice change.  In addition to chemotherapy and targeted therapy of hematological malignancies, this symposium will focus on individualized treatment options. In-depth discussion of novel agents at various stages of clinical development will be given significant focus. This enduring online activity is designed to provide clinical decision-making strategies for integration of novel therapeutic options.

This program consists of 4 continuing education activites.

Module 1 — Multiple Myeloma — 1.5 AMA PRA Category 1™ Credit Hours

Module 2 — Lymphoma — 2.0 AMA PRA Category 1™ Credit Hours

Module 3 — Leukemia — 1.75 AMA PRA Category 1™ Credit Hours

Module 4 — Symptom Management, Cost and Reimbursement — 1.0 AMA PRA Category 1™ Credit Hours